More News
8 December 2020
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery4 December 2020
Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies3 December 2020
Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation1 December 2020
Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies1 December 2020
ViGeneron and WuXi Advanced Therapies enter Strategic Manufacturing Partnership For Next-Generation Ophthalmic Gene Therapy1 December 2020
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement1 December 2020
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio23 November 2020
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb23 November 2020
Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology23 November 2020
Merck to Acquire OncoImmune20 November 2020
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement19 November 2020
ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease19 November 2020
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes18 November 2020
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies16 November 2020
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases13 November 2020
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly6 November 2020
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis6 November 2020
Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies6 November 2020
Novo Nordisk to acquire Emisphere Technologies and obtain ownership of the Eligen® SNAC oral delivery technology5 November 2020
Merck to Acquire VelosBioNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports